My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
April 2014
Patient Care and Science
NIAID/NIH Announce Antibiotic Research Funding Opportunity
The Antibacterial Leadership Group (ARLG), an initiative funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH), has announced that $62 million is available to support clinical research in antibacterial resistance. The funds will be allocated over a period of six and a half years. In addition, up to $7.5 million annually of in-kind support will be available for high-resource clinical trials.

The ARLG, which includes several IDSA members, is tasked with developing and prioritizing a clinical research agenda and designing, implementing, and conducting clinical studies to address the growing public health threat of antibacterial resistance. The group has identified four high-priority areas of research: infections caused by Gram-negative bacteria, infections caused by Gram-positive bacteria, antimicrobial stewardship and infection prevention, and diagnostics. The ARLG will be accepting proposals from the scientific community for clinical research that address one or more of these high-priority areas.

IDSA has long advocated for NIAID to fund more antimicrobial resistance research in a coordinated way. More information on the research funding opportunities can be found on the ARLG website.  



< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Clinical Practice Management
Pocketcards Now Available for HIV and Vaccination Guidelines
IDSA Takes Leadership Role in Developing Quality Measures for ID
Policy and Advocacy
IDSA Weighs in on Fiscal Year 2015 Appropriations Process
IDSA Joins SHEA in Commenting on Respiratory Protective Devices
HIVMA, IDSA Members Named to Work Group as HOPE Implementation Begins
Patient Care and Science
NIAID/NIH Announce Antibiotic Research Funding Opportunity
New Guidance Highlights How to Reduce Catheter - Associated UTIs
EIN Update: EIN Links Clinicians and Researchers
Science Speaks
The Center for Global Health Policy’s blog, Science Speaks, covered new Hep C guidelines from WHO, the new U.S. Global AIDS Coordinator, promising news in antiretroviral access, and more
Education and Resources
OFID Names New Associate Editors
Share Your Feedback on IDSA’s Journals
You and Your Colleagues
26 Medical Students Set to Explore ID Firsthand
Members on the Move
New Members
Top Stories
From the President: What’s Keeping Young People From Choosing ID?
Journal Club
Patient Access to Medicare Act: Disappointment for SGR Fix, Win for Diagnostics
Progress Continues on Antimicrobial Resistance as New Drugs Loom on Horizon
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.